Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data

8Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Concerns about the role of chronically used medications in the clinical outcomes of the coronavirus disease 2019 (COVID-19) have remarkable potential for the breakdown of non-communicable diseases (NCDs) management by imposing ambivalence toward medication continuation. This study aimed to investigate the association of single or combinations of chronically used medications in NCDs with clinical outcomes of COVID-19. Methods: This retrospective study was conducted on the intersection of two databases, the Iranian COVID-19 registry and Iran Health Insurance Organization. The primary outcome was death due to COVID-19 hospitalization, and secondary outcomes included length of hospital stay, Intensive Care Unit (ICU) admission, and ventilation therapy. The Anatomical Therapeutic Chemical (ATC) classification system was used for medication grouping. The frequent pattern growth algorithm was utilized to investigate the effect of medication combinations on COVID-19 outcomes. Findings: Aspirin with chronic use in 10.8% of hospitalized COVID-19 patients was the most frequently used medication, followed by Atorvastatin (9.2%) and Losartan (8.0%). Adrenergics in combination with corticosteroids inhalants (ACIs) with an odds ratio (OR) of 0.79 (95% confidence interval: 0.68–0.92) were the most associated medications with less chance of ventilation therapy. Oxicams had the least OR of 0.80 (0.73–0.87) for COVID-19 death, followed by ACIs [0.85 (0.77–0.95)] and Biguanides [0.86 (0.82–0.91)]. Conclusion: The chronic use of most frequently used medications for NCDs management was not associated with poor COVID-19 outcomes. Thus, when indicated, physicians need to discourage patients with NCDs from discontinuing their medications for fear of possible adverse effects on COVID-19 prognosis.

References Powered by Scopus

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

11218Citations
N/AReaders
Get full text

Dexamethasone in hospitalized patients with covid-19

7690Citations
N/AReaders
Get full text

An interactive web-based dashboard to track COVID-19 in real time

7045Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Patterns of case fatality and hospitalization duration among nearly 1 million hospitalized COVID-19 patients covered by Iran Health Insurance Organization (IHIO) over two years of pandemic: An analysis of associated factors

3Citations
N/AReaders
Get full text

Exploring the clinical benefit of ventilation therapy across various patient groups with COVID-19 using real-world data

3Citations
N/AReaders
Get full text

Pathological Interplay and Clinical Complications between COVID-19 and Cardiovascular Diseases: An Overview in 2023

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Malekpour, M. R., Abbasi-Kangevari, M., Shojaee, A., Saeedi Moghaddam, S., Ghamari, S. H., Rashidi, M. M., … Farzadfar, F. (2023). Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1061307

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

80%

Professor / Associate Prof. 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

57%

Engineering 2

29%

Chemical Engineering 1

14%

Save time finding and organizing research with Mendeley

Sign up for free